XML 85 R72.htm IDEA: XBRL DOCUMENT v3.6.0.2
Segment and Geographic Information (Details) - USD ($)
3 Months Ended 9 Months Ended
Jan. 27, 2017
Jan. 29, 2016
Jan. 27, 2017
Jan. 29, 2016
Segment Reporting Information [Line Items]        
Net sales $ 7,283,000,000 $ 6,934,000,000 $ 21,794,000,000 $ 21,266,000,000
Income before Income Taxes by Reportable Segment        
Special charge (100,000,000) 0 (100,000,000) 0
Restructuring charges, net (21,000,000) (19,000,000) (162,000,000) (159,000,000)
Certain litigation charges (218,000,000) 0 (300,000,000) (26,000,000)
Acquisition-related items (68,000,000) (63,000,000) (148,000,000) (183,000,000)
Interest expense, net (180,000,000) (176,000,000) (532,000,000) (584,000,000)
Income from operations before income taxes 967,000,000 1,179,000,000 3,167,000,000 3,202,000,000
Americas [Member]        
Segment Reporting Information [Line Items]        
Net sales 4,417,000,000 4,229,000,000 13,185,000,000 13,064,000,000
U.S. [Member]        
Segment Reporting Information [Line Items]        
Net sales 4,100,000,000 4,000,000,000 12,300,000,000 12,200,000,000
EMEA [Member]        
Segment Reporting Information [Line Items]        
Net sales 1,652,000,000 1,607,000,000 4,895,000,000 4,843,000,000
Asia Pacific [Member]        
Segment Reporting Information [Line Items]        
Net sales 818,000,000 729,000,000 2,530,000,000 2,235,000,000
Greater China [Member]        
Segment Reporting Information [Line Items]        
Net sales 396,000,000 369,000,000 1,184,000,000 1,124,000,000
Operating Segments [Member]        
Income before Income Taxes by Reportable Segment        
Income from operations before income taxes 1,695,000,000 1,644,000,000 4,931,000,000 5,100,000,000
Segment Reconciling Items [Member]        
Income before Income Taxes by Reportable Segment        
Special charge (100,000,000) 0 (100,000,000) 0
Impact of inventory step-up 0 0 (38,000,000) (226,000,000)
Restructuring charges, net (21,000,000) (19,000,000) (172,000,000) (159,000,000)
Certain litigation charges (218,000,000) 0 (300,000,000) (26,000,000)
Acquisition-related items (68,000,000) (63,000,000) (148,000,000) (183,000,000)
Interest expense, net (180,000,000) (176,000,000) (532,000,000) (584,000,000)
Corporate, Non-Segment [Member]        
Income before Income Taxes by Reportable Segment        
Corporate (141,000,000) (207,000,000) (474,000,000) (720,000,000)
Cardiac and Vascular Group [Member]        
Segment Reporting Information [Line Items]        
Net sales 2,548,000,000 2,410,000,000 7,650,000,000 7,460,000,000
Cardiac and Vascular Group [Member] | Operating Segments [Member]        
Income before Income Taxes by Reportable Segment        
Income from operations before income taxes 683,000,000 726,000,000 2,055,000,000 2,298,000,000
Minimally Invasive Therapies Group [Member]        
Segment Reporting Information [Line Items]        
Net sales 2,417,000,000 2,291,000,000 7,314,000,000 7,103,000,000
Minimally Invasive Therapies Group [Member] | Operating Segments [Member]        
Income before Income Taxes by Reportable Segment        
Income from operations before income taxes 328,000,000 282,000,000 958,000,000 963,000,000
Restorative Therapies Group [Member]        
Segment Reporting Information [Line Items]        
Net sales 1,817,000,000 1,759,000,000 5,415,000,000 5,335,000,000
Restorative Therapies Group [Member] | Operating Segments [Member]        
Income before Income Taxes by Reportable Segment        
Income from operations before income taxes 535,000,000 496,000,000 1,543,000,000 1,460,000,000
Diabetes Group [Member]        
Segment Reporting Information [Line Items]        
Net sales 501,000,000 474,000,000 1,415,000,000 1,368,000,000
Diabetes Group [Member] | Operating Segments [Member]        
Income before Income Taxes by Reportable Segment        
Income from operations before income taxes $ 149,000,000 $ 140,000,000 $ 375,000,000 $ 379,000,000